2bnr

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
{{Seed}}
 
[[Image:2bnr.png|left|200px]]
[[Image:2bnr.png|left|200px]]
Line 20: Line 19:
==About this Structure==
==About this Structure==
-
2BNR is a 5 chains structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2BNR OCA].
+
[[2bnr]] is a 5 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2BNR OCA].
==Reference==
==Reference==
-
<ref group="xtra">PMID:15837811</ref><references group="xtra"/>
+
<ref group="xtra">PMID:15837811</ref><ref group="xtra">PMID:10878370</ref><references group="xtra"/>
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Bossi, G.]]
[[Category: Bossi, G.]]
Line 47: Line 46:
[[Category: Flu]]
[[Category: Flu]]
[[Category: Glycoprotein]]
[[Category: Glycoprotein]]
 +
[[Category: Immune system/receptor]]
 +
[[Category: Immune system/receptor/complex]]
[[Category: Immunodominance]]
[[Category: Immunodominance]]
[[Category: Mhc]]
[[Category: Mhc]]
Line 57: Line 58:
[[Category: Tcr]]
[[Category: Tcr]]
[[Category: Transmembrane]]
[[Category: Transmembrane]]
- 
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Feb 17 09:05:24 2009''
 

Revision as of 22:49, 14 March 2011

Template:STRUCTURE 2bnr

STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES

Template:ABSTRACT PUBMED 15837811

About this Structure

2bnr is a 5 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

  • Chen JL, Stewart-Jones G, Bossi G, Lissin NM, Wooldridge L, Choi EM, Held G, Dunbar PR, Esnouf RM, Sami M, Boulter JM, Rizkallah P, Renner C, Sewell A, van der Merwe PA, Jakobsen BK, Griffiths G, Jones EY, Cerundolo V. Structural and kinetic basis for heightened immunogenicity of T cell vaccines. J Exp Med. 2005 Apr 18;201(8):1243-55. PMID:15837811 doi:10.1084/jem.20042323
  • Chen JL, Dunbar PR, Gileadi U, Jager E, Gnjatic S, Nagata Y, Stockert E, Panicali DL, Chen YT, Knuth A, Old LJ, Cerundolo V. Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL. J Immunol. 2000 Jul 15;165(2):948-55. PMID:10878370

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools